CCL2 and preeclampsia: In addition to providing normative values and clarifying the benefits of expanded cytokine panels, our results reveal distinct biomarker profiles in infants that can inform future mechanistic studies, including significantly increased MCP-1 among infants delivered due to maternal preeclampsia and significantly increased CRP among infants subsequently identified to have chorioamnionitis plus funisitis on placental pathology.